Active Ingredient: ARIPIPRAZOLE
Proprietary Name: ABILIFY
Dosage Form; Route of Administration: INJECTABLE; INTRAMUSCULAR
Strength: 9.75MG/1.3ML (7.5MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N021866
Product Number: 001
Approval Date: Sep 20, 2006
Applicant Holder Full Name: OTSUKA PHARMACEUTICAL CO LTD
Marketing Status:
Discontinued
Patent and Exclusivity Information
